The activity of interleukin (IL)-9 on B cells was analyzed in vivo using tr
ansgenic mice that constitutively express this cytokine. These mice show an
increase in both baseline and antigen-specific immunoglobulin concentratio
ns for all isotypes tested. Analysis of B cell populations showed a specifi
c expansion of Mac-1(+) B-1 cells in the peritoneal and pleuropericardial c
avities, and in the blood of IL-9 transgenic mice. In normal mice, the IL-9
receptor was found to be expressed by CD5(+) as well as CD5(-) B-1 cells,
and repeated injections of IL-9 resulted in accumulation of B-1 cells in th
e peritoneal cavity, as observed in transgenic animals. Unlike other mouse
models, such as IL-5 transgenic mice, in which expansion of the B-1 populat
ion is associated with high levels of autoantibodies, IL-9 did not stimulat
e the production of autoantibodies in vivo, and most of the expanded cells
were found to belong to the B-1b subset (IgM(+)Mac-1(+)CD5(-)). In addition
, we found that these IL-9-expanded B-1b cells do not share the well-docume
nted antibromelain-treated red blood cell specificity of CD5(+) B-1a cells.
The increase of antigen-specific antibody concentration in immunized mice
suggests that these B-1 cells are directly or indirectly involved in antibo
dy responses in IL-9 transgenic mice.